1Cell provides an AI-powered single‑cell liquid biopsy platform that isolates circulating tumor cells and generates multi‑omics profiles in real time. The system combines high‑throughput cell capture hardware with machine‑learning analytics to deliver molecular signatures for early cancer detection, therapy response prediction, and disease monitoring.
Funding
Funding not disclosed
Founders
Product
Problem
Current cancer diagnostics often rely on bulk tissue analysis or circulating tumor DNA, which can miss rare circulating tumor cells and lack the resolution to capture tumor heterogeneity at the single-cell level. This limits early detection, precise therapy selection, and real-time monitoring of disease progression.
Solution
1Cell.Ai offers an AI-driven single-cell multi-omics platform that isolates and profiles individual circulating tumor cells (CTCs) and other tumor cells in real time. The platform combines next‑generation sequencing, advanced machine learning, and unified bioinformatics to generate high‑resolution molecular signatures for each cell. These signatures enable rapid identification of aggressive tumor phenotypes, prediction of therapy response, and continuous monitoring of disease dynamics. By delivering actionable insights directly to clinicians, researchers, and biopharma partners, the solution supports earlier diagnosis, personalized treatment planning, and accelerated biomarker discovery.
Target Audience
Primary customers include oncologists and clinical laboratories seeking non‑invasive diagnostics, translational researchers studying tumor biology, and pharmaceutical/biotech companies developing targeted therapies and biomarker‑driven trials.
Features
- OncoIncytes® liquid biopsy system that captures live, intact CTCs for downstream multi‑omics analysis
- 1Cell SOLO AI‑driven single‑cell isolation hardware with high‑throughput, contamination‑free capture
- Integrated AI/ML pipelines that process NGS data to produce real‑time molecular profiles and predictive analytics
- 1Cell iCORE platform for multi‑modal data integration (genomics, imaging, clinical) and biomarker discovery
- Scalable cloud‑based analytics with customizable dashboards for clinicians and researchers
- Compatibility with biopharma workflows for patient stratification and precision‑medicine trial design